請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29465
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 黃青真 | |
dc.contributor.author | Yung-Ju Chen | en |
dc.contributor.author | 陳永如 | zh_TW |
dc.date.accessioned | 2021-06-13T01:07:48Z | - |
dc.date.available | 2008-07-08 | |
dc.date.copyright | 2007-07-27 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-23 | |
dc.identifier.citation | 上海中醫學院編 (1975),中草藥學,商務印書館香港分館,香港。
許鴻源、陳玉盤、許順吉、許照信、陳建志、張憲昌 (1985),簡明藥材學,新醫藥出版社,台北市。 王春霞 (2004) 菊花化學成分的研究進展。中藥材 27:224-226。 王薇、蔡健 (2004) 桂花總黃酮的提取工藝。廣州食品工業科技 20:53-54。 汪濤、蔣惠娣、季燕萍、徐娟華 (2001) 菊花水提液對心腦組織的體內外抗氧化作用。中藥材 24:122-124。 周輝政、王崇安、許淳森、吳文惠 (2002) 植物雌激素與停經前婦女保健。中華民國營養學會雜誌 27:56-66。 徐文昭 (2000) 月季花花瓣的黃酮類成分的研究。南京中醫藥大學學報 (自然科學版) 16:225-226。 劉迎春、張秀春 (1999) 茉莉花粗多糖抗腹水肝癌的初步研究。福州師專學報 (自然科學版) 19:78-80。 張海娟、徐俊駒、于麗麗、陳業高 (2004) 茉莉的化學與藥理研究進展。雲南化工 31:15-18。 張曦、吳錫信 (2004) 月季花的藥理與臨床應用探討。吉林中醫藥 24:47。 盛春元、趙桂宏 (2006) 玫瑰花與月季花的鑒別。首都醫藥 8:52。 許欣榮、趙華英 (1983) 中藥月季花和玫瑰花的性狀鑒別。中藥材科技 38:36。 許淳森、周輝政、王崇安、吳文惠 (2004) 植物雌激素與停經後婦女保健。中華民國營養學會雜誌 29:1-11。 陳林、盧秉國 (2003) “荷花茶”生化成分的分析研究。(2003) 19:197-200。 喻晶、胡文淑 (1997) 甲基蓮心碱對兔血小板聚集功能的影響。藥學學報 32:1-4。 臧德奎、向其柏、劉玉蓮、郝日明 (2003) 中國桂花的研究歷史、現狀與桂花品種國際登錄。植物資源與環境學報 12:49-53。 劉金旗、吳德林、王蘭、劉勁松、王舉濤 (2001) 菊花中黃酮苷的含量分析。32:308-310。 燕業飛、何鋼、謝碧霞 (2006) 桂花研究概況。湖北林業科技 3:37-40。 盧文生 (2003) 中藥玫瑰花與月季花的鑒別。中國藥業 12:62。 顧瑤華、秦民堅 (2004) 我國藥用菊花的化學及藥理學研究新進展。中國野生植物資源 23:7-9。 吳雅玲 (1996) 膳食油脂對大鼠脂肪組織中 PPARγ 與相關基因 mRNA 表現及化學組成影響之探討。台大農化所碩士論文。 許珊菁 (2006) 鼠模式中高脂飲食、肥胖與脂質調控基因之表現。台大微生所博士論文。 謝婉郁 (2005) 山苦瓜改善血糖血脂代謝異常之效應探討。台大微生所碩士論文。 Adlercreutz, H., Bannwart, C., Wahala, K., Makela, T., Brunow, G., Hase, T., Arosemena, P.J., Kellis, J.T., Jr., and Vickery, L.E. (1993). Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. The Journal of steroid biochemistry and molecular biology 44, 147-153. Amri, E.Z., Ailhaud, G., and Grimaldi, P.A. (1994). Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. Journal of lipid research 35, 930-937. Araghiniknam, M., Chung, S., Nelson-White, T., Eskelson, C., and Watson, R.R. (1996). Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans. Life sciences 59, PL147-157. Ascenzi, P., Bocedi, A., and Marino, M. (2006). Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Molecular aspects of medicine 27, 299-402. Banner, C.D., Gottlicher, M., Widmark, E., Sjovall, J., Rafter, J.J., and Gustafsson, J.A. (1993). A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma. Journal of lipid research 34, 1583-1591. Boue, S.M., Wiese, T.E., Nehls, S., Burow, M.E., Elliott, S., Carter-Wientjes, C.H., Shih, B.Y., McLachlan, J.A., and Cleveland, T.E. (2003). Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. Journal of agricultural and food chemistry 51, 2193-2199. Bramlett, K.S., and Burris, T.P. (2003). Target specificity of selective estrogen receptor modulators within human endometrial cancer cells. The Journal of steroid biochemistry and molecular biology 86, 27-34. Brodie, A.E., Manning, V.A., Ferguson, K.R., Jewell, D.E., and Hu, C.Y. (1999). Conjugated linoleic acid inhibits differentiation of pre- and post- confluent 3T3-L1 preadipocytes but inhibits cell proliferation only in preconfluent cells. The Journal of nutrition 129, 602-606. Burgermeister, E., Schnoebelen, A., Flament, A., Benz, J., Stihle, M., Gsell, B., Rufer, A., Ruf, A., Kuhn, B., Marki, H.P., et al. (2006). A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro. Molecular endocrinology 20, 809-830. Cai, Y.Z., Xing, J., Sun, M., Zhan, Z.Q., and Corke, H. (2005). Phenolic antioxidants (hydrolyzable tannins, flavonols, and anthocyanins) identified by LC-ESI-MS and MALDI-QIT-TOF MS from Rosa chinensis flowers. Journal of agricultural and food chemistry 53, 9940-9948. Carmichael, A.R., and Bates, T. (2004). Obesity and breast cancer: a review of the literature. Breast (Edinburgh, Scotland) 13, 85-92. Carr, M.C. (2003). The emergence of the metabolic syndrome with menopause. The Journal of clinical endocrinology and metabolism 88, 2404-2411. Chang, S.J., Lee, Y.C., Liu, S.Y., and Chang, T.W. (2004). Chinese yam (Dioscorea alata cv. Tainung No. 2) feeding exhibited antioxidative effects in hyperhomocysteinemia rats. Journal of agricultural and food chemistry 52, 1720-1725. Chen, T., Li, L.P., Lu, X.Y., Jiang, H.D., and Zeng, S. (2007). Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. Journal of agricultural and food chemistry 55, 273-277. Collins-Burow, B.M., Burow, M.E., Duong, B.N., and McLachlan, J.A. (2000). Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms. Nutrition and cancer 38, 229-244. Cowherd, R.M., Lyle, R.E., and McGehee, R.E., Jr. (1999). Molecular regulation of adipocyte differentiation. Seminars in cell & developmental biology 10, 3-10. Dang, Z.C., Audinot, V., Papapoulos, S.E., Boutin, J.A., and Lowik, C.W. (2003). Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genistein. The Journal of biological chemistry 278, 962-967. Desvergne, B., and Wahli, W. (1999). Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine reviews 20, 649-688. Dixon, R.A. (2004). Phytoestrogens. Annual review of plant biology 55, 225-261. Emons, G., Grundker, C., Gunthert, A.R., Westphalen, S., Kavanagh, J., and Verschraegen, C. (2003). GnRH antagonists in the treatment of gynecological and breast cancers. Endocrine-related cancer 10, 291-299. Enmark, E., and Gustafsson, J.A. (1999). Oestrogen receptors - an overview. Journal of internal medicine 246, 133-138. Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjold, M., and Gustafsson, J.A. (1997). Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. The Journal of clinical endocrinology and metabolism 82, 4258-4265. Fievet, C., Fruchart, J.C., and Staels, B. (2006). PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Current opinion in pharmacology 6, 606-614. Gao, X., Li, B., Jiang, H., Liu, F., Xu, D., and Liu, Z. (2007). Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia 78, 12-15. Gottardis, M.M., Robinson, S.P., Satyaswaroop, P.G., and Jordan, V.C. (1988). Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer research 48, 812-815. Gregoire, F.M., Smas, C.M., and Sul, H.S. (1998). Understanding adipocyte differentiation. Physiological reviews 78, 783-809. Grundy, S.M., Brewer, H.B., Jr., Cleeman, J.I., Smith, S.C., Jr., and Lenfant, C. (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438. Guri, A.J., Hontecillas, R., and Bassaganya-Riera, J. (2006). Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition. Clinical nutrition (Edinburgh, Scotland) 25, 871-885. Hewitt, S.C., and Korach, K.S. (2003). Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues. Reproduction (Cambridge, England) 125, 143-149. Horton, J.D. (2002). Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochemical Society transactions 30, 1091-1095 Hung, H. (2004). Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol. Journal of cellular physiology 198, 197-208. Innocenti, G., Vegeto, E., Dall'Acqua, S., Ciana, P., Giorgetti, M., Agradi, E., Sozzi, A., Fico, G., and Tome, F. (2007). In vitro estrogenic activity of Achillea millefolium L. Phytomedicine 14, 147-152. Jacobs, M.N., and Lewis, D.F. (2002). Steroid hormone receptors and dietary ligands: a selected review. The Proceedings of the Nutrition Society 61, 105-122. Jedrzejuk, D., and Milewicz, A. (2005). Consequences of menopause in women with diabetes mellitus - a clinical problem. Gynecol Endocrinol 21, 280-286. Jordan, V.C. (2003a). Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. Journal of medicinal chemistry 46, 883-908. Jordan, V.C. (2003b). Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. Journal of medicinal chemistry 46, 1081-1111 Jordan, V.C. (2004). Selective estrogen receptor modulation: concept and consequences in cancer. Cancer cell 5, 207-213. Jung, H.A., Kim, J.E., Chung, H.Y., and Choi, J.S. (2003). Antioxidant principles of Nelumbo nucifera stamens. Archives of pharmacal research 26, 279-285. Kaneuchi, M., Sasaki, M., Tanaka, Y., Sakuragi, N., Fujimoto, S., and Dahiya, R. (2003). Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. International journal of oncology 22, 159-164. Kang, K., Liu, W., Albright, K.J., Park, Y., and Pariza, M.W. (2003). trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR gamma expression. Biochemical and biophysical research communications 303, 795-799. Kim, H.J., Takahashi, M., and Ezaki, O. (1999). Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mrnas. The Journal of biological chemistry 274, 25892-25898. Kim, H.K., Della-Fera, M., Lin, J., and Baile, C.A. (2006). Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. The Journal of nutrition 136, 2965-2969. Kim, M.J., Kim, H.N., Kang, K.S., Baek, N.I., Kim, D.K., Kim, Y.S., Jeon, B.H., and Kim, S.H. (2004). Methanol extract of Dioscoreae Rhizoma inhibits pro-inflammatory cytokines and mediators in the synoviocytes of rheumatoid arthritis. International immunopharmacology 4, 1489-1497. Kim, S., Shin, H.J., Kim, S.Y., Kim, J.H., Lee, Y.S., Kim, D.H., and Lee, M.O. (2004). Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Molecular and cellular endocrinology 220, 51-58. Kim, S., Sohn, I., Lee, Y.S., and Lee, Y.S. (2005). Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. The Journal of nutrition 135, 33-41 Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., van der Burg, B., and Gustafsson, J.A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263. Kuo, Y.C., Lin, Y.L., Liu, C.P., and Tsai, W.J. (2005). Herpes simplex virus type 1 propagation in HeLa cells interrupted by Nelumbo nucifera. Journal of biomedical science 12, 1021-1034. Lee, C.H., Olson, P., and Evans, R.M. (2003). Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144, 2201-2207. Leung, L.K., Po, L.S., Lau, T.Y., and Yuen, Y.M. (2004). Effect of dietary flavonols on oestrogen receptor transactivation and cell death induction. The British journal of nutrition 91, 831-839. Lovejoy, J.C. (2003). The menopause and obesity. Primary care 30, 317-325. Mak, P., Leung, Y.K., Tang, W.Y., Harwood, C., and Ho, S.M. (2006). Apigenin suppresses cancer cell growth through ERbeta. Neoplasia (New York, NY 8, 896-904. McAnuff, M.A., Harding, W.W., Omoruyi, F.O., Jacobs, H., Morrison, E.Y., and Asemota, H.N. (2005). Hypoglycemic effects of steroidal sapogenins isolated from Jamaican bitter yam, Dioscorea polygonoides. Food Chem Toxicol 43, 1667-1672. McAnuff-Harding, M.A., Omoruyi, F.O., and Asemota, H.N. (2006). Intestinal disaccharidases and some renal enzymes in streptozotocin-induced diabetic rats fed sapogenin extract from bitter yam (Dioscorea polygonoides). Life sciences 78, 2595-2600. Mezei, O., Banz, W.J., Steger, R.W., Peluso, M.R., Winters, T.A., and Shay, N. (2003). Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. The Journal of nutrition 133, 1238-1243. Mezei, O., Li, Y., Mullen, E., Ross-Viola, J.S., and Shay, N.F. (2006). Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms. Physiological genomics 26, 8-14. Miodini, P., Fioravanti, L., Di Fronzo, G., and Cappelletti, V. (1999). The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. British journal of cancer 80, 1150-1155. Mittra, S., Sangle, G., Tandon, R., Sharma, S., Roy, S., Khanna, V., Gupta, A., Sattigeri, J., Sharma, L., Priyadarsiny, P., et al. (2007). Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema? British journal of pharmacology 150, 480-487. Miyazawa, M., and Hisama, M. (2003). Antimutagenic activity of flavonoids from Chrysanthemum morifolium. Bioscience, biotechnology, and biochemistry 67, 2091-2099. Moriarty, K., Kim, K.H., and Bender, J.R. (2006). Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147, 5557-5563. Mueller, S.O., and Korach, K.S. (2001). Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Current opinion in pharmacology 1, 613-619. Mukherjee, P.K., Saha, K., Das, J., Pal, M., and Saha, B.P. (1997a). Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta medica 63, 367-369. Mukherjee, P.K., Saha, K., Pal, M., and Saha, B.P. (1997b). Effect of Nelumbo nucifera rhizome extract on blood sugar level in rats. Journal of ethnopharmacology 58, 207-213. Oh, S.M., and Chung, K.H. (2004). Estrogenic activities of Ginkgo biloba extracts. Life sciences 74, 1325-1335. Ono, Y., Hattori, E., Fukaya, Y., Imai, S., and Ohizumi, Y. (2006). Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. Journal of ethnopharmacology 106, 238-244. Pinelli, A., Godio, C., Laghezza, A., Mitro, N., Fracchiolla, G., Tortorella, V., Lavecchia, A., Novellino, E., Fruchart, J.C., Staels, B., et al. (2005). Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity. Journal of medicinal chemistry 48, 5509-5519. Poehlman, E.T. (2002). Menopause, energy expenditure, and body composition. Acta obstetricia et gynecologica Scandinavica 81, 603-611. Rago, R., Mitchen, J., and Wilding, G. (1990). DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Analytical biochemistry 191, 31-34. Ramirez-Zacarias, J.L., Castro-Munozledo, F., and Kuri-Harcuch, W. (1992). Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97, 493-497. Ricketts, M.L., Moore, D.D., Banz, W.J., Mezei, O., and Shay, N.F. (2005). Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. The Journal of nutritional biochemistry 16, 321-330. Rosano, G.M., Vitale, C., and Tulli, A. (2006). Managing cardiovascular risk in menopausal women. Climacteric 9 Suppl 1, 19-27. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 288, 321-333. Sasson, S., and Notides, A.C. (1983). Estriol and estrone interaction with the estrogen receptor. I. Temperature-induced modulation of the cooperative binding of [3H]estriol and [3H]estrone to the estrogen receptor. The Journal of biological chemistry 258, 8113-8117. Shen, P., Liu, M.H., Ng, T.Y., Chan, Y.H., and Yong, E.L. (2006). Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. The Journal of nutrition 136, 899-905. Sinha, S., Mukherjee, P.K., Mukherjee, K., Pal, M., Mandal, S.C., and Saha, B.P. (2000). Evaluation of antipyretic potential of Nelumbo nucifera stalk extract. Phytother Res 14, 272-274. Slater, T.F., Sawyer, B., and Straeuli, U. (1963). Studies on Succinate-Tetrazolium Reductase Systems. Iii. Points of Coupling of Four Different Tetrazolium Salts. Biochimica et biophysica acta 77, 383-393. Sohn, D.H., Kim, Y.C., Oh, S.H., Park, E.J., Li, X., and Lee, B.H. (2003). Hepatoprotective and free radical scavenging effects of Nelumbo nucifera. Phytomedicine 10, 165-169. Spiegelman, B.M., and Flier, J.S. (1996). Adipogenesis and obesity: rounding out the big picture. Cell 87, 377-389. Talukder, M.J., and Nessa, J. (1998). Effect of Nelumbo nucifera rhizome extract on the gastrointestinal tract of rat. Bangladesh Medical Research Council bulletin 24, 6-9. Ukiya, M., Akihisa, T., Yasukawa, K., Kasahara, Y., Kimura, Y., Koike, K., Nikaido, T., and Takido, M. (2001). Constituents of compositae plants. 2. Triterpene diols, triols, and their 3-o-fatty acid esters from edible chrysanthemum flower extract and their anti-inflammatory effects. Journal of agricultural and food chemistry 49, 3187-3197. van Meeuwen, J.A., Korthagen, N., de Jong, P.C., Piersma, A.H., and van den Berg, M. (2007). (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol Appl Pharmacol. Wdziekonski, B., Villageois, P., and Dani, C. (2007). Differentiation of Mouse Embryonic Stem Cells and of Human Adult Stem Cells into Adipocytes. In Current Protocols in Cell Biology (John Wiley & Sonsm Inc.). Willson, T.M., and Wahli, W. (1997). Peroxisome proliferator-activated receptor agonists. Current opinion in chemical biology 1, 235-241. Wu, M.J., Wang, L., Weng, C.Y., and Yen, J.H. (2003). Antioxidant activity of methanol extract of the lotus leaf (Nelumbo nucifera Gertn.). The American journal of Chinese medicine 31, 687-698. Wu, W.H., Liu, L.Y., Chung, C.J., Jou, H.J., and Wang, T.A. (2005). Estrogenic effect of yam ingestion in healthy postmenopausal women. Journal of the American College of Nutrition 24, 235-243. Wynn, S.G., and Fougere, B.J. (2007). Veterinary Herbal Medicine (Mosby Eisevier). Yang, Y., Shang, W., Zhou, L., Jiang, B., Jin, H., and Chen, M. (2007). Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells. Biochemical and biophysical research communications 353, 225-230. Zava, D.T., and Duwe, G. (1997). Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutrition and cancer 27, 31-40. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29465 | - |
dc.description.abstract | 婦女於停經後因雌激素分泌不足,而產生停經症候群症狀並會增加罹患代謝症候群的風險,進而有可能引發第二型糖尿病或心血管疾病。目前已知 PPAR (peroxisome proliferators activated receptor) α/γ 雙效活化物是治療代謝症候群重要標的,且 PPARγ 的活化會影響脂肪細胞的分化與脂質生合成。本研究即是檢驗已知有植物雌激素活性的山藥與苜蓿芽乙酸乙酯萃取物與六種山藥雌激素純化物,19-6-3-1、19-8-3-2-1、26-3、26-5-2、28-1 與 61-1-6 活化 PPARα 與 PPARγ 的能力並了解其對是否會影響前脂肪細胞 3T3-L1 的增生與脂質生合成。另一方面,又篩選鑑定新的五種花草藥:菊花、茉莉、蓮花、桂花及月季花 80% 甲醇(aq) 萃取物的植物雌激素效應。
將山藥與苜蓿芽凍乾粉末以乙酸乙酯萃取,萃取物回溶於絕對酒精,處理經共轉染 Gal4-rPPARα/γ chimeric receptor 與 (UAS)4-ALP (alkaline phosphatase) reporter 之 CHO-K1 細胞,分析報導基因 ALP 之活性,測試山藥與苜蓿芽乙酸乙酯萃取物與山藥雌激素純化物的 PPAR 活性。3T3-L1 的增生效應是將細胞以樣品處理 24 與48 小時後,以 MTT 染色法評估細胞增生,比較與 vehicle 組之差異。3T3-L1 分化實驗則是以樣品於各種分化期處理不同時間來了解山藥、苜蓿芽與苦瓜乙酸乙酯萃取物處理的時間點對於分化的影響,分別是將萃取物於分化全期、分化前期、分化後期及已分化期處理 3T3-L1 細胞,分化完成後測定其三酸甘油酯含量作為分化程度之指標。 山藥與苜蓿芽乙酸乙酯萃取物於 PPARα 之最大相對活化百分比分別約可達正對照組 10 μM WY 14643 之 40% 與 50%,於 PPARγ 則分別約為 0.1 μM BRL 49653 之 25% 與20%。兩種萃取物皆以活化 PPARα 的效果較佳;山藥雌激素純化物 19-6-3-1 與 26-3 活化 PPARα 與 PPARγ 的能力則皆為 12% 左右。而在 3T3-L1 增生方面,山藥乙酸乙酯萃取物於 pre-confluent (起始細胞數 2500/well) 及 confluent (起始細胞數 5000/well) 時期皆促進細胞增生。而苜蓿芽乙酸乙酯萃取物則於 pre-confluent 時期促進細胞增生,但於 confluent 則降低 MTT 染色值。山藥乙酸乙酯萃取物於 3T3-L1 分化全期、後期與已分化期皆顯著增加三酸甘油酯堆積。苦瓜乙酸乙酯萃取物處理可增加三酸甘油酯堆積,且有劑量效應。但苜蓿芽乙酸乙酯萃取物於各時期添加皆不影響細胞三酸甘油酯堆積。總括來看,山藥與苜蓿芽乙酸乙酯萃取物及山藥純化物 19-6-3-1 與 26-3 可活化 PPARα 與 PPARγ,為 (或含) PPARα/γ 雙效活化物,且山藥乙酸乙酯萃取物會促進前脂肪細胞 3T3-L1 的增生、分化與脂質累積能力,而苜蓿芽乙酸乙酯萃取物則在 PPARα/γ 活化的同時卻不易促進脂肪組織增生。 五種花草藥萃取物先以 CHO-K1 細胞共轉染 Gal4-hER (estrogen receptor) α/β chimeric receptor 與 (UAS)4-ALP reporter 測試活化 ERα 與 ERβ 的能力。再進行人類乳癌細胞株 MCF-7 與子宮內膜癌細胞株 Ishikawa 增生試驗 (MTT 試驗),以了解萃取物對雌激素依賴型癌細胞的活性。另亦測試樣品對 Ishikawa 細胞中 ER 標的基因 ALP (alkaline phosphatase) 活性之影響,以評估具 ER 活性之 花草藥萃取物樣品於含 ER 細胞中,透過 ER 調控基因表現之狀況。 菊花、茉莉、蓮花、桂花與月季花萃取物皆是以活化 ERβ 的活性較高,Ishikawa ER 標的基因 ALP 的活性大致與 ER 轉染活性相符,以菊花萃取物的活性最高。於 MCF-7 增生試驗中,五種花草藥萃取物皆會使 MTT 染色值上升,但以茉莉萃取物的效應為最低。Ishikawa 子宮內膜癌細胞增生試驗中,桂花萃取物可以抑制細胞的增生,其他萃取物皆會促使細胞 MTT 染色值增加,但仍是以茉莉萃取物的效應最低。縱觀 MCF-7 與 Ishikawa 細胞以 MTT 染色值為指標之增生試驗結果,以茉莉萃取物的結果最為理想,因其於 50 μg/mL 濃度下 ERβ 的活性約可達最大相對活化百分比的 19% (與 Ishikawa ALP 試驗結果相似),但是於此濃度下,子宮內膜癌細胞株 Ishikawa 並不會被促進增生,乳癌細胞株 MCF-7 則只有少量的增生 (<15%),故可提供植物雌激素活性,但不易刺激癌細胞增生。 由本論文結果可得知具有植物雌激素活性的山藥與苜蓿芽乙酸乙酯萃取物有活化 PPARα 與 γ 的能力,但前者促進前脂肪細胞 3T3-L1 的增生並分化,但後者則否。並篩選出五種新的具植物雌激素活性之花草藥,其中茉莉 80% 甲醇(aq) 萃取物不致引發乳癌及子宮內膜癌細胞之顯著生長,具有開發的潛力。 | zh_TW |
dc.description.abstract | Postmenopausal women suffer not only from peri-menopausal syndromes but also from increased risks of metabolic syndrome, type 2 diabetes, and cardiovascular diseases. A few of phytoestrogens, such as isoflavones, have been shown to activate PPAR (peroxisome proliferators activated reportor) α/γ which is speculated as one of the mechanism of its beneficial effects in improving metabolic syndrome. This study first aimed at testing the phytoestrogenic yam and alfalfa EAEs (ethyl acetate extracts) and six yam estrogenic purified compounds—19-6-3-1, 19-8-3-2-1, 26-3, 26-5-2, 28-1 and 61-1-6—for their PPAR activity and effects on proliferation and differentiation of 3T3-L1 adipocyte, as PPARγ is known for regulating adipocyte differentiation. A second aim is to characterize five phytoestrogenic flower herb extracts, Chrysanthemum morifolium, Jasminum sambac, Nelumbo nucifera, Osmanthus fragran, and Rosa chinensis, were tested for estrogenic effects.
Lyophilized powder of yam and alfalfa were extracted by ethyl acetate and their EAEs were obtained. To test PPAR activity, CHO-K1 cells were co-transfected with vectors carrying Gal4-rPPARα/γ chimeric receptor and (UAS)4-ALP (alkaline phosphatase) reporter, and treated with yam and alfalfa EAEs and yam estrogenic active compounds. The maximal % of induction relative to 10 μM WY 14643 on PPARα were 40% (yam EAE) and 50% (alfalfa EAE), and to 0.1 μM BRL 49653 on PPARγ were 25% (yam EAE) and 20% (alfalfa EAE). Yam estrogenic purified compound 19-6-3-1 and 26-3 can also activated both PPARα and PPARγ. Proliferation of 3T3-L1 was monitored by the MTT assay after 24 or 48 hr treatment at 2 different starting cell density, to examine the effect before and after confluence. Yam EAE increased 3T3-L1 cell growth at all doses tested. On the other hand, alfalfa EAE suppresses 3T3-L1 proliferation at confluent stage but enhances at pre-confluent stage. To test EAE samples on differentiation, differentiating 3T3-L1 cells were treated with yam, alfalfa, and 2381 bitter gourd EAEs at full stage, early stage only, late stage only or post-differentiation stage only. Cellular TG, protein and DNA contents were measured 8 days post differentiation. Yam EAE treatment throughout full stages of differentiation, at late stage, or at post-differentiation, all stimulates adpogenesis as indicated by TG/DNA. 2381 bitter gourd EAE can only stimulates adpogenesis when treated throughout full stages of differentiation. However, alfalfa EAE did not change these parameters measured. Taking together, both yam and alfalfa EAEs and yam estrogenic purified compounds 19-6-3-1 and 26-3 activated both PPARα and PPARγ, but only yam significantly increased 3T3-L1 proliferation and differentiation. To test ER (estrogen receptor) activity of the five flower herbs, CHO-K1 cells are co-transfected with vectors carrying Gal4-hERα/β chimeric receptor and (UAS)4-ALP reporter, and treated with 80% methanol extracts of the five flower herbs. All five flower herb extracts exhibited higher activity on ERβ than on ER α. The five extracts were then tested for their effect on the proliferation on human breast cancer cell line MCF-7 and endometrial cancer cell line Ishikawa using the MTT assay. Except for Jasminum sambac extract, all the remaining 4 flower herb extracts increased MTT values to various extent, support the data on ER activation. Jasminum sambac extract did not significantly increased MTT value of Ichikawa cells and increase MTT value of MCF-7 cells to a low extent. To test the sample extract on the ER target gene expression, Ishikawa cells treated with sample extracts were assayed for ALP activity. Except for OF, all the remaining four extracts increased ALP activity of Ishikawa cells indicating ER active compounds in these extract can also act on natural ER. Among the five samples, Jasminum sambac extract showed significant estrogenic activity in both of the transactivation assay and the Ishikawa cell ALP assay, but did not increase the proliferation of Ishikawa cells and enhanced MCF-7 cell growth on to a limited extent. In conclusion, phytoestrogenic yam and alflalfa EAEs are able to activate both PPARα and PPARγ, but only yam EAEs increased 3T3-L1 proliferation and differentiation. Five flower herbs were demonstrated to contain phytoestrogenic compounds. Among these, Jasminum sambac extract might have highest potential to be developed as a dietary supplement for post-menopausal women. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T01:07:48Z (GMT). No. of bitstreams: 1 ntu-96-R94b47302-1.pdf: 2706532 bytes, checksum: 7debbeccc1b813da7ad776de36b91aef (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 總 目 錄
口試委員會審定書 ………………………………………………………………… i 誌謝 …………………………………………………………………………… ii 中文摘要 ………………………………………………………………………… v 英文摘要 ……………………………………………………………………… viii 第一章 緒論…………………………………………………… 1 第一節 前言 …………………………………………………… 1 第二節 文獻回顧 ……………………………………………… 3 一、ER (estrogen receptor) …………………………………………… 3 (一) ER 的種類 ………………………………………………… 3 (二) ER 的分佈 ………………………………………………… 3 (三) ER 的作用機制 …………………………………………… 5 (四) ER 的 ligands …………………………………………… 6 二、PPAR (peroxisome proliferators-activated receptor) …………… 8 (一) PPAR 的種類 ……………………………………………… 8 (二) PPAR 的 ligands ………………………………………… 8 (三) PPAR 的作用機制 ………………………………………… 11 (四) 代謝症候群 ……………………………………………… 12 (五) PPARγ 與脂肪細胞分化 ………………………………… 13 三、植物雌激素活性食材 …………………………………………… 15 (一) 菊花 ……………………………………………………… 15 (二) 茉莉 ……………………………………………………… 15 (三) 蓮花 ……………………………………………………… 15 (四) 桂花 ……………………………………………………… 16 (五) 月季花 …………………………………………………… 16 (六) 山藥 ……………………………………………………… 17 (七) 苜蓿芽 …………………………………………………… 17 第三節 實驗假說與設計 ……………………………………… 18 第二章 具雌激素活性食材樣品之 PPAR 活化能力 …… 20 第一節 前言 …………………………………………………… 20 第二節 材料與方法 …………………………………………… 21 一、試劑與器材 ……………………………………………………… 21 (一) 細胞株 …………………………………………………… 21 (二) 細胞培養用試劑 ………………………………………… 21 (三) 短暫轉染用試劑與器材 ………………………………… 23 (四) 分析報導基因 SEAP 試驗用試劑與器材 …………… 24 (五) 測試樣品 ………………………………………………… 24 二、實驗方法 ……………………………………………………… 26 (一) 細胞培養 ………………………………………………… 26 (二) 短暫轉染試驗 …………………………………………… 27 (三) 報導基因 ALP 活性分析 ……………………………… 28 (四) MTT 染色法細胞存活率分析 ………………………… 29 (五) 統計分析 ………………………………………………… 29 第三節 結果 …………………………………………………… 30 第四節 討論與結論 …………………………………………… 38 一、Hep-G2 細胞株PPAR transcativation assay 轉染效率不佳 …… 38 二、具雌激素活性之山藥、苜蓿芽乙酸乙酯萃取物可活化PPARα/γ. 40 三、結論 ……………………………………………………………… 40 第三章 山藥、苜蓿芽與苦瓜乙酸乙酯萃取物對 3T3-L1 前脂肪細胞株增生與分化之影響 …………………… 42 第一節 前言 …………………………………………………… 42 第二節 材料與方法 …………………………………………… 43 一、試劑與器材 ……………………………………………………… 43 (一) 細胞株 …………………………………………………… 43 (二) 細胞培養用試劑 ………………………………………… 43 (三) 3T3-L1 分化用試劑 …………………………………… 44 (四) 3T3-L1 分化培養基 …………………………………… 44 (五) 三酸甘油酯定量分析用試劑組 ………………………… 45 (六) 蛋白質定量分析用試劑 ………………………………… 45 (七) DNA 定量分析用試劑 ………………………………… 45 (八) 脂肪細胞油紅染色用試劑 ……………………………… 46 (九) 測試樣品 ………………………………………………… 46 二、實驗方法 ……………………………………………………… 47 (一) 細胞培養 ………………………………………………… 47 (二) 3T3-L1 細胞增生試驗 ………………………………… 47 (三) MTT 染色法細胞存活率分析 ………………………… 48 (四) 3T3-L1 分化試驗 ……………………………………… 48 (五) 3T3-L1 脂肪細胞三酸甘油酯分析試驗 ……………… 49 (六) 3T3-L1 脂肪細胞油紅染色試驗 ……………………… 50 (七) 統計分析 ………………………………………………… 51 第三節 結果 …………………………………………………… 52 第四節 討論與結論 …………………………………………… 73 一、3T3-L1 前脂肪細胞株於不同細胞密度下之增生效應 ……… 73 二、3T3-L1 前脂肪細胞株分化條件的掌控 ……………………… 73 三、山藥、苜蓿芽與苦瓜乙酸乙酯萃取物影響 3T3-L1 前脂肪細胞株增生與分化 ………………………………………………………… 74 四、結論 ……………………………………………………………… 75 第四章 花草藥樣品之雌激素效應………………………… 76 第一節 前言 …………………………………………………… 76 第二節 材料與方法 …………………………………………… 78 一、試劑與器材 ……………………………………………………… 78 (一) 細胞株 …………………………………………………… 78 (二) 細胞培養用試劑 ………………………………………… 78 (三) 短暫轉染用試劑與器材 ………………………………… 79 (四) 分析報導基因 SEAP 試驗用試劑與器材 …………… 80 (五) 分析 Ishikawa 細胞 ALP 活性用試劑與器材 ……… 80 (六) 測試樣品 ………………………………………………… 81 二、實驗方法 ……………………………………………………… 82 (一) 細胞培養 ………………………………………………… 82 (二) 短暫轉染試驗 …………………………………………… 83 (三) 報導基因 ALP 活性分析 ……………………………… 83 (四) MTT 染色法細胞存活率分析 ………………………… 84 (五) MCF-7 細胞增生試驗 …………………………………… 84 (六) Ishikawa 細胞 ALP 與增生試驗………………………… 84 (七) 統計分析 ………………………………………………… 85 第三節 結果 …………………………………………………… 86 第四節 討論與結論 …………………………………………… 95 一、五種 80% 甲醇(aq) 花草藥萃取物具有雌激素活性 ………… 95 二、80% 甲醇(aq) 菊花萃取物的雌激素總體效應 ……………… 97 三、80% 甲醇(aq) 茉莉萃取物的雌激素總體效應 ……………… 97 四、80% 甲醇(aq) 蓮花萃取物的雌激素總體效應 ……………… 98 五、80% 甲醇(aq) 桂花萃取物的雌激素總體效應 ……………… 98 六、80% 甲醇(aq) 月季花萃取物的雌激素總體效應 …………… 99 七、結論 ……………………………………………………………… 99 第五章 綜合討論與總結論………………………………… 100 第一節 綜合討論 …………………………………………… 100 第二節 總結論 ……………………………………………… 102 第六章 參考文獻…………………………………………… 104 附錄一……………………………………………………… 116 附錄二……………………………………………………… 118 | |
dc.language.iso | zh-TW | |
dc.title | 數種植物雌激素食材萃物對 PPAR、脂肪細胞生成及雌激素活性特質鑑定 | zh_TW |
dc.title | Characterization of PPAR, Adipogenesis and Estrogenic Activities of Some Phytoestrogenic Food Materials | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳曉鈴,吳文惠,趙蓓敏,蘇慧敏 | |
dc.subject.keyword | 植物雌激素,ER,PPAR,代謝症候群,脂質生合成, | zh_TW |
dc.subject.keyword | phytoestrogen,ER,PPAR,metabolic syndrome,adipogenesis, | en |
dc.relation.page | 118 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-23 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 微生物與生化學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 2.64 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。